"For the management of diabetes mellitus, the CCRAS has developed a formulation namely AYUSH-82 from five ayurvedic medicinal plants.
"The trails of the drug has shown significant reduction in blood sugar levels along with clinical improvements. No toxic effects were noted during the trial," AYUSH Minister Shripad Yesso Naik said in a written reply.
He said that the Council has initiated action to commercialise AYUSH-82 and till now Dabur India, Kudos Laboratory India and La Granade Herbs and Pharma have been given licenses for manufacturing it.
"CSIR has reported that its constituent laboratory namely Central Institute of Medicinal and Aromatic Plants (Lucknow) in a study undertaken in collaboration with Go-Vigyan Anusandhan Kendra in Nagpur have found novel use of cow urine distillate as activity enhancer and availability facilitatory for bio-active molecules including anti-infective and anti-cancer agents," Naik said.
He said that cow urine distillate was found to possess the property of bio-enhancement of an anti-cancer natural agent 'taxol' which is produced in microscopic amounts by the Yew tree.
"Further a white crystalline precipitate prepared from the cow urine distillate also showed similar activity as cow urine distillate. A US patent on the research finding has also been obtained.
"Public and Private research institutes may seek grant from the government under various schemes of Ministry of AYUSH. However there is no plan with the Ministry of AYUSH to extend separate assistance to the institutions engaged in developing cancer medicines from cow urine only," he added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
